Who
Derek A. Small
Director
Company insider
Files Form 4 as: Director, Innoviva; CEO and President, Assembly Biosciences.
In numbers
- Trades disclosed
- 18
- Buys
- 3
- Sells
- 0
- Bought
- $155K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 10 Feb 2016
- Last trade
- 4 May 2026
- Last filed
- 6 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 May 2026filed 6 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —9,786 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —9,786 at $0.00 | filing |
| 19 May 2025filed 21 May 2025 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 19 May 2025filed 21 May 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —12,077 at $0.00 | filing |
| 17 Jun 2024filed 20 Jun 2024 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 17 Jun 2024filed 20 Jun 2024 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —13,923 at $0.00 | filing |
| 2 Jan 2020filed 3 Jan 2020 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 29 Mar 2019filed 2 Apr 2019 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 29 Mar 2019filed 2 Apr 2019 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —32,500 at $0.00 | filing |
| 19 Jul 2018filed 20 Jul 2018 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Bought | $49K1,200 at $41.19 | filing |
| 19 Jul 2018filed 20 Jul 2018 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Bought | $50K1,200 at $41.77 | filing |
| 29 Mar 2018filed 30 Mar 2018 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —32,500 at $0.00 | filing |
| 29 Mar 2018filed 30 Mar 2018 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 29 Mar 2017filed 31 Mar 2017 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 11 Feb 2016filed 12 Feb 2016 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Bought | $8,6461,555 at $5.56 | filing |
| 10 Feb 2016filed 12 Feb 2016 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Bought | $47K8,445 at $5.52 | filing |
News
No headline names them, or the companies they trade most, lately.